Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Maintenance and care are essential components of a successful cancer journey, especially after receiving immunotherapy. At Liv Hospital, we recognize that the treatment phase is only the beginning; the real challenge often lies in sustaining health, managing side effects, and preserving quality of life. Studies show that up to 30% of patients experience delayed toxicities that can emerge weeks or months after the last infusion, underscoring the need for vigilant post‑treatment monitoring.
This page is designed for international patients who have completed immunotherapy and are seeking clear, evidence‑based guidance on what to expect next. We cover everything from routine laboratory checks to nutrition plans, psychological support, and how our 360‑degree patient services can keep you connected with world‑class care while you travel.
Whether you are preparing for discharge, planning a return visit, or coordinating care with a local physician, the information below will help you build a personalized maintenance and care roadmap that aligns with your treatment goals.
After the active phase of immunotherapy, the body continues to adapt as the immune system remains primed to recognize cancer cells. This period, often referred to as the maintenance phase, focuses on sustaining the therapeutic response while minimizing adverse events. Key objectives include:
Our multidisciplinary team creates a customized schedule that balances clinical vigilance with patient convenience. Below is a comparison of common maintenance strategies employed after checkpoint inhibitor therapy.
Choosing the right approach depends on tumor type, response depth, and individual health status. Our international care coordinators assist in aligning the chosen plan with your home‑country medical network, ensuring seamless continuity.
Immune‑related toxicities can affect any organ system, with skin, gastrointestinal, endocrine, and pulmonary manifestations being the most common. Early detection and prompt intervention are cornerstones of effective maintenance and care. Patients are encouraged to keep a daily symptom diary and report any new or worsening issues to their care team.
Typical monitoring includes:
When an irAE is identified, management follows a graded approach:
Liv Hospital’s on‑site pharmacists and immunology nurses provide 24‑hour tele‑support for international patients, enabling rapid response regardless of time zone.
Optimal nutrition supports immune function and helps mitigate treatment‑related fatigue. A balanced diet rich in protein, omega‑3 fatty acids, and antioxidants can enhance tissue repair and maintain muscle mass. Key recommendations include:
Physical activity, even low‑impact exercises like walking or yoga, improves circulation and reduces the risk of cardiovascular complications that sometimes accompany long‑term immunotherapy. Below is a sample weekly activity plan suitable for most patients during the maintenance phase.
Our nutritionists, fluent in multiple languages, can tailor meal plans to cultural preferences and dietary restrictions, ensuring that international patients feel comfortable and supported.
Regular follow‑up visits allow clinicians to assess disease status, adjust maintenance therapy, and address any emerging concerns. A typical schedule after immunotherapy may look like this:
For patients traveling back to their home country, we provide a detailed “Medical Transfer Package” that includes:
Our dedicated International Patient Office coordinates with local oncologists to align these timelines with regional standards, reducing gaps in care.
The emotional impact of cancer treatment can be profound, and maintaining mental well‑being is a vital part of maintenance and care. Liv Hospital offers a suite of services designed to address anxiety, depression, and the social challenges of living far from home.
Available resources include:
Research indicates that patients who engage in structured psychosocial programs experience a 20% improvement in treatment adherence and overall satisfaction. Our multilingual staff ensures that language barriers do not hinder access to these essential services.
Liv Hospital is a JCI‑accredited, internationally recognized cancer center in Istanbul, offering cutting‑edge immunotherapy combined with a full spectrum of supportive services. Our 360‑degree international patient program handles everything from airport transfers to interpreter‑assisted consultations, allowing you to focus on recovery. With a dedicated team of oncologists, immunologists, and patient‑care specialists, we deliver personalized maintenance and care plans that meet global standards while respecting cultural preferences.
Ready to secure your post‑treatment plan? Contact our International Patient Office today to schedule a personalized consultation and ensure seamless continuity of care wherever you are.
Send us all your questions or requests, and our expert team will assist you.
After the active immunotherapy phase, the immune system remains primed to attack cancer cells. Maintenance care includes regular imaging, blood tests, and low‑dose therapies that keep the immune response active while minimizing toxicity. The goal is to detect early signs of relapse, manage immune‑related adverse events, and support overall health through nutrition, exercise, and psychosocial services. Liv Hospital creates individualized schedules that balance medical vigilance with patient convenience, especially for those traveling internationally.
The standard follow‑up schedule begins with a tele‑consultation within the first month to review symptom diaries and lab results. Blood work is performed weekly for the first eight weeks, then transitions to monthly checks. Chest imaging (X‑ray or CT) is recommended every three months for lung‑related concerns, while comprehensive CT or PET‑CT scans are usually done at three and six months, followed by six‑monthly intervals thereafter. Adjustments are made based on tumor type, response depth, and any emerging side effects.
Immune‑related adverse events (irAEs) can affect skin, gastrointestinal, endocrine, and pulmonary systems. Mild (grade 1) events are treated symptomatically while continuing therapy. Moderate (grade 2) events usually require holding immunotherapy and starting low‑dose steroids. Severe (grade 3‑4) events demand discontinuation of immunotherapy, high‑dose steroids, and specialist referral. Liv Hospital’s on‑site pharmacists and immunology nurses provide 24‑hour tele‑support to ensure rapid intervention, regardless of the patient’s time zone.
Low‑dose immunotherapy maintains immune activation while reducing overall drug exposure. Clinical data suggest it can prolong response in certain tumor types, but the risk of immune‑related adverse events is higher compared to observation alone. The decision depends on tumor biology, depth of response, and patient tolerance. Liv Hospital’s multidisciplinary team evaluates these factors and discusses the risk‑benefit profile with each patient.
Liv Hospital offers board‑certified psycho‑oncologists for one‑on‑one counseling via video or in‑person visits. Support groups are conducted in several languages, fostering peer connection among international patients. Mind‑body workshops include guided meditation, art therapy, and music therapy to reduce anxiety and improve quality of life. A patient‑navigator assists with visa extensions, accommodation, and local transportation, ensuring that emotional and practical needs are met throughout the maintenance phase.
Your Comparison List (you must select at least 2 packages)
